Inventor · disambiguated record
Baskar Nammalwar
Also filed as: NAMMALWAR BASKAR
9 granted patents·10 pending applications·22 citations·filing 2013–2023
83Inventor score
Files withFORGE THERAPEUTICS INC9BLACKSMITH MEDICINES INC7UNIV LOUISIANA STATE2KALYANARAMAN RAMNARAYAN1
Top patents by PatentIndex Score
19 records- 0190US11407740B2Antibacterial compoundsFORGE THERAPEUTICS INC·Filed 2021·Granted Aug 9, 2022·5 cites·17 claims
- 0289US10875832B2Substituted pyrimidines for treating bacterial infectionsFORGE THERAPEUTICS INC·Filed 2019·Granted Dec 29, 2020·4 cites·16 claims
- 0389US10414735B2Substituted hydroxypyrimidinones for treating bacterial infectionsFORGE THERAPEUTICS INC·Filed 2016·Granted Sep 17, 2019·5 cites·19 claims
- 0484US11731962B2LpxC inhibitor and methods of makingBLACKSMITH MEDICINES INC·Filed 2021·Granted Aug 22, 2023·1 cites·18 claims
- 0584US11021471B2Antibacterial compoundsFORGE THERAPEUTICS INC·Filed 2018·Granted Jun 1, 2021·3 cites·19 claims
- 0681US10611747B2Pyrone based compounds for treating bacterial infectionsFORGE THERAPEUTICS INC·Filed 2016·Granted Apr 7, 2020·4 cites·14 claims
- 0770US2024002373A1Lpxc inhibitor and methods of makingBLACKSMITH MEDICINES INC·Filed 2023·Application pending·0 cites
- 0869US2023201214A1Lpxc inhibitor, formulations, and uses thereofBLACKSMITH MEDICINES INC·Filed 2023·Application pending·0 cites
- 0967US12325699B2Antibacterial compoundsBLACKSMITH MEDICINES INC·Filed 2022·Granted Jun 10, 2025·0 cites·18 claims
- 1065US2021078957A1Substituted pyrimidines for treating bacterial infectionsFORGE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1162US2021315902A1Lpxc inhibitor, formulations, and uses thereofFORGE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1255US2024150298A1Antibacterial compoundsBLACKSMITH MEDICINES INC·Filed 2022·Application pending·0 cites
- 1354US2024166609A1Antibacterial compoundsBLACKSMITH MEDICINES INC·Filed 2022·Application pending·0 cites
- 1453US2023382891A1Glutaminyl-peptide cyclotransferase like (qpctl) protein inhibitors and uses thereofBLACKSMITH MEDICINES INC·Filed 2021·Application pending·0 cites
- 1549US12251370B2Small molecule inhibitors of the BfrB:Bfd interactionUNIV LOUISIANA STATE·Filed 2019·Granted Mar 18, 2025·0 cites·20 claims
- 1646US12263156B2Use of small molecule inhibitors of the BfrB:Bfd interaction in biofilmsUNIV LOUISIANA STATE·Filed 2021·Granted Apr 1, 2025·0 cites·20 claims
- 1742US2022081421A1Antibacterial compoundsFORGE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1838US2015065509A1Highly 6-substituted -2,4-diaminopyrimidines as inhibitors of anthraxKALYANARAMAN RAMNARAYAN·Filed 2013·Application pending·0 cites
- 1937US2020095236A1Antibacterial compoundsFORGE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Baskar Nammalwar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →